Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway

被引:44
作者
Coghill, David [1 ]
Seth, Sarah [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Dundee DD1 9SY, Scotland
关键词
Attention-deficit/hyperactivity disorder; Titration; Treatment response; Inadequate response; MEDICATION ALGORITHM PROJECT; CONSENSUS CONFERENCE PANEL; LONG-TERM OUTCOMES; RATING-SCALE; MULTIMODAL TREATMENT; MULTIPLE REPORTS; PART II; CHILDREN; METHYLPHENIDATE; RELIABILITY;
D O I
10.1186/s13034-015-0083-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Attention-deficit/hyperactivity disorder (ADHD) has become a major aspect of the work of child and adolescent psychiatrists and paediatricians in the UK. In Scotland, Child and Adolescent Mental Health Services were required to address an increase in referral rates and changes in evidence-based medicine and guidelines without additional funding. In response to this, clinicians in Dundee have, over the past 15 years, pioneered the use of integrated psychiatric, paediatric, nursing, occupational therapy, dietetic and psychological care with the development of a clearly structured, evidence-based assessment and treatment pathway to provide effective therapy for children and adolescents with ADHD. The Dundee ADHD Clinical Care Pathway (DACCP) uses standard protocols for assessment, titration and routine monitoring of clinical care and treatment outcomes, with much of the clinical work being nurse led. The DACCP has received international attention and has been used as a template for service development in many countries. This review describes the four key stages of the clinical care pathway (referral and pre-assessment; assessment, diagnosis and treatment planning; initiating treatment; and continuing care) and discusses translation of the DACCP into other healthcare systems. Tools for healthcare professionals to use or adapt according to their own clinical settings are also provided.
引用
收藏
页数:14
相关论文
共 68 条
  • [11] [Anonymous], ATTENTION DEFICIT HY
  • [12] [Anonymous], GUID US METH RIT EQ
  • [13] [Anonymous], CAN ADHS PRACT GUID
  • [14] [Anonymous], ATT DEF HYP DIS DIAG
  • [15] [Anonymous], DIAGNOSTIC INTERVIEW
  • [16] [Anonymous], 2007, J AM ACAD CHILD ADOL, V46, P107
  • [17] [Anonymous], CADDRA ADHD ASS TOOL
  • [18] [Anonymous], 1992, ICD 10 CLASS MENT BE
  • [19] Long-acting medications for the hyperkinetic disorders -: A systematic review and European treatment guideline
    Banaschewski, Tobias
    Coghill, David
    Santosh, Paramala
    Zuddas, Alessandro
    Asherson, Philip
    Buitelaar, Jan
    Danckaerts, Marina
    Doepfner, Manfred
    Faraone, Stephen V.
    Rothenberger, Aribert
    Sergeant, Joseph
    Steinhausen, Hans-Christoph
    Sonuga-Barke, Edmund J. S.
    Taylor, Eric
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (08) : 476 - 495
  • [20] THE MTA AT 8
    Banaschewski, Tobias
    Buitelaar, Jan
    Coghill, David R.
    Sergeant, Joseph A.
    Sonuga-Barke, Edmund J. S.
    Zuddas, Alessandro
    Taylor, Eric
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (11) : 1120 - 1122